Janssen Pharmaceuticals
Belgian pharmaceutical company
Belgian pharmaceutical company
Johnson & Johnson Innovative Medicine (formerly Janssen Pharmaceuticals) is a Belgian pharmaceutical company headquartered in Beerse, Belgium, and wholly owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen. In 1961, Janssen Pharmaceuticals was purchased by the New Jersey–based American corporation Johnson & Johnson. It became part of Johnson & Johnson Pharmaceutical Research and Development (J&J PRD), which was later renamed Janssen Research and Development, LLC (JRD). This division conducts research and development activities related to a wide range of human medical disorders, including mental illness, neurological disorders, anesthesia and analgesia, gastrointestinal disorders, fungal infections, HIV/AIDS, allergies, and cancer. Janssen and Ortho-McNeil Pharmaceutical were later placed into the Ortho-McNeil-Janssen group within Johnson & Johnson.
Open boosters, collect cards and trade them. Free to play.
Play for free